Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on October 2, 2026

Oct. 2, 2026

Backhaul Market Report Highlights Key Segments, Regional Trends And Major Competitors

Indeterminate EIN Presswire

Oct. 2, 2026

Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization

Indeterminate GlobeNewswire

Oct. 2, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

NETSOL Technologies appoints Michael Ramsey as Vice President of Sales for Asset Finance in the Americas

Indeterminate GlobeNewswire

Oct. 2, 2026

Persephone Biosciences to Provide 50,000 Free Doses of Groundbreaking Infant and Toddler Synbiotics

Indeterminate GlobeNewswire

Oct. 2, 2026

EMD Electronics Opens New R&D Facility in Wisconsin to Accelerate Advanced Semiconductor Materials Innovation

Indeterminate GlobeNewswire

Oct. 2, 2026

Satellogic Announces Successful Launch of First Merlin Satellite

Indeterminate GlobeNewswire

Oct. 2, 2026

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Indeterminate GlobeNewswire

Oct. 2, 2026

Applied Digital Brings an Additional 75 MW of AI Infrastructure Online at Polaris Forge 1

Indeterminate GlobeNewswire

Oct. 2, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week

Indeterminate GlobeNewswire

Oct. 2, 2026

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

Oct. 2, 2026

European Medicines Agency Validates Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Review

Indeterminate GlobeNewswire

Oct. 2, 2026

Bull opens new production building in France and doubles production capacity to meet the new challenges of AI

Indeterminate GlobeNewswire

Oct. 2, 2026

Bull inaugure son nouveau bâtiment de production à Angers et double ses capacités de production pour répondre aux nouveaux défis de l’IA

Indeterminate GlobeNewswire

Oct. 2, 2026

Traini Introduces PetVisits an AI Native Advertising Platform for the Pet Industry

Indeterminate GlobeNewswire

Oct. 2, 2026

Addex Therapeutics Announces Executive Management Changes

Indeterminate GlobeNewswire

Oct. 2, 2026

Quantexa Deepens Investment in Málaga with New Innovation Hub

Indeterminate GlobeNewswire

Oct. 2, 2026

Luciphia Launches Reversible Fleece and Sherpa Pet Blanket Designed to Protect Shared Family Spaces

Indeterminate GlobeNewswire